b

biote Corp
NASDAQ:BTMD

Watchlist Manager
biote Corp
NASDAQ:BTMD
Watchlist
Price: 6.57 USD -2.23% Market Closed
Market Cap: 356.2m USD
Have any thoughts about
biote Corp?
Write Note

Intrinsic Value

The intrinsic value of one BTMD stock under the Base Case scenario is 10.55 USD. Compared to the current market price of 6.57 USD, biote Corp is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BTMD Intrinsic Value
10.55 USD
Undervaluation 38%
Intrinsic Value
Price
b
Worst Case
Base Case
Best Case

Valuation Backtest
biote Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BTMD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BTMD?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about biote Corp

Provide an overview of the primary business activities
of biote Corp.

What unique competitive advantages
does biote Corp hold over its rivals?

What risks and challenges
does biote Corp face in the near future?

Has there been any significant insider trading activity
in biote Corp recently?

Summarize the latest earnings call
of biote Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for biote Corp.

Provide P/S
for biote Corp.

Provide P/E
for biote Corp.

Provide P/OCF
for biote Corp.

Provide P/FCFE
for biote Corp.

Provide P/B
for biote Corp.

Provide EV/S
for biote Corp.

Provide EV/GP
for biote Corp.

Provide EV/EBITDA
for biote Corp.

Provide EV/EBIT
for biote Corp.

Provide EV/OCF
for biote Corp.

Provide EV/FCFF
for biote Corp.

Provide EV/IC
for biote Corp.

Show me price targets
for biote Corp made by professional analysts.

What are the Revenue projections
for biote Corp?

How accurate were the past Revenue estimates
for biote Corp?

What are the Net Income projections
for biote Corp?

How accurate were the past Net Income estimates
for biote Corp?

What are the EPS projections
for biote Corp?

How accurate were the past EPS estimates
for biote Corp?

What are the EBIT projections
for biote Corp?

How accurate were the past EBIT estimates
for biote Corp?

Compare the revenue forecasts
for biote Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of biote Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of biote Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of biote Corp compared to its peers.

Compare the P/E ratios
of biote Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing biote Corp with its peers.

Analyze the financial leverage
of biote Corp compared to its main competitors.

Show all profitability ratios
for biote Corp.

Provide ROE
for biote Corp.

Provide ROA
for biote Corp.

Provide ROIC
for biote Corp.

Provide ROCE
for biote Corp.

Provide Gross Margin
for biote Corp.

Provide Operating Margin
for biote Corp.

Provide Net Margin
for biote Corp.

Provide FCF Margin
for biote Corp.

Show all solvency ratios
for biote Corp.

Provide D/E Ratio
for biote Corp.

Provide D/A Ratio
for biote Corp.

Provide Interest Coverage Ratio
for biote Corp.

Provide Altman Z-Score Ratio
for biote Corp.

Provide Quick Ratio
for biote Corp.

Provide Current Ratio
for biote Corp.

Provide Cash Ratio
for biote Corp.

What is the historical Revenue growth
over the last 5 years for biote Corp?

What is the historical Net Income growth
over the last 5 years for biote Corp?

What is the current Free Cash Flow
of biote Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for biote Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
biote Corp

Current Assets 61.8m
Cash & Short-Term Investments 26.4m
Receivables 8.6m
Other Current Assets 26.8m
Non-Current Assets 31.1m
PP&E 6.6m
Intangibles 16.4m
Other Non-Current Assets 8.1m
Current Liabilities 46.3m
Accounts Payable 5.8m
Accrued Liabilities 5.2m
Other Current Liabilities 35.2m
Non-Current Liabilities 190m
Long-Term Debt 157m
Other Non-Current Liabilities 33m
Efficiency

Earnings Waterfall
biote Corp

Revenue
187.2m USD
Cost of Revenue
-56.8m USD
Gross Profit
130.4m USD
Operating Expenses
-100.6m USD
Operating Income
29.8m USD
Other Expenses
-22.9m USD
Net Income
6.9m USD

Free Cash Flow Analysis
biote Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BTMD Profitability Score
Profitability Due Diligence

biote Corp's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional ROIC
Positive 3-Year Average ROE
63/100
Profitability
Score

biote Corp's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

BTMD Solvency Score
Solvency Due Diligence

biote Corp's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Average Altman Z-Score
Long-Term Solvency
37/100
Solvency
Score

biote Corp's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BTMD Price Targets Summary
biote Corp

Wall Street analysts forecast BTMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BTMD is 9.78 USD with a low forecast of 7.07 USD and a high forecast of 12.6 USD.

Lowest
Price Target
7.07 USD
8% Upside
Average
Price Target
9.78 USD
49% Upside
Highest
Price Target
12.6 USD
92% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BTMD?

Click here to dive deeper.

Dividends

biote Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for BTMD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BTMD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

biote Corp

Country

United States of America

Industry

Pharmaceuticals

Market Cap

356.2m USD

Dividend Yield

0%

Description

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas. The company went IPO on 2021-03-02. The firm provides components to enable Biote-certified practitioners to establish, build, and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. Its Biote Method is a comprehensive, end-to-end practice-building platform that provides Biote-certified practitioners with components specifically developed for practitioners in the hormone optimization space, such as Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The firm trains practitioners how to identify and treat early indicators of hormone-related aging conditions. The company also sells a complementary Biote-branded line of dietary supplements.

Contact

TEXAS
Irving
1875 W. Walnut Hill Ln #100, Floor 5
+19724869346
haymakeracquisition.com

IPO

2021-03-02

Employees

-

Officers

Executive Chairman
Mr. Marc D. Beer
CEO & Director
Ms. Teresa S. Weber
VP of Business Development, General Counsel & Corporate Secretary
Ms. Mary Elizabeth Conlon
Chief Financial Officer
Mr. Robert C. Peterson
Chief Information Officer
Mr. John J. Olsen
Chief People Officer
Mr. James Elliott Gibbs II
Show More
Chief Digital Officer
Mr. Richard Kevin Key
Head of Nutraceuticals
Mr. Jade Beutler
Chief Clinical Advisor & Member of Medical Advisory Board
Dr. Cory Rice D.O.
Show Less

See Also

Discover More
What is the Intrinsic Value of one BTMD stock?

The intrinsic value of one BTMD stock under the Base Case scenario is 10.55 USD.

Is BTMD stock undervalued or overvalued?

Compared to the current market price of 6.57 USD, biote Corp is Undervalued by 38%.

Back to Top